• 1. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Professional Introduction to Compound with CAS No 1227494-41-8 and Product Name 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one

Compound with the CAS number 1227494-41-8 and the product name 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one represents a significant advancement in the field of chemical and pharmaceutical research. This compound, characterized by its unique structural and functional properties, has garnered considerable attention due to its potential applications in drug development and molecular biology. The presence of a fluoro group and a hydroxymethyl substituent in its molecular framework imparts distinct chemical reactivity and biological activity, making it a valuable candidate for further exploration.

The 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one structure is derived from pyridine, a heterocyclic aromatic compound that serves as a fundamental scaffold in medicinal chemistry. The introduction of fluorine at the 5-position and a hydroxymethyl group at the 3-position enhances the compound's solubility, metabolic stability, and binding affinity to biological targets. These modifications are critical in optimizing pharmacokinetic profiles, which are essential for the development of effective therapeutic agents.

Recent studies have highlighted the importance of fluorinated pyridines in the design of novel pharmaceuticals. The fluorine atom, due to its electronegativity and small size, can significantly influence the electronic properties of molecules, thereby affecting their interactions with biological receptors. In particular, 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one has been investigated for its potential role in inhibiting various enzymes and receptors involved in inflammatory and infectious diseases. Its ability to modulate these pathways makes it a promising candidate for further clinical development.

In addition to its pharmacological applications, 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one has shown promise in biochemical research. The compound's unique reactivity allows it to participate in various chemical transformations, making it useful as an intermediate in synthesizing more complex molecules. Researchers have leveraged its structural features to develop novel synthetic routes that could be applied in industrial-scale production of other bioactive compounds.

The integration of computational methods into the study of 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one has further accelerated its investigation. Advanced computational techniques, such as molecular dynamics simulations and quantum mechanical calculations, have enabled scientists to predict the compound's behavior with high accuracy. These predictions are crucial for designing experiments and optimizing reaction conditions, thereby reducing experimental costs and time.

One of the most intriguing aspects of 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one is its potential in developing antiviral agents. The compound's ability to interfere with viral replication mechanisms has been explored through both experimental and theoretical studies. By targeting specific viral enzymes or receptors, it may offer a new strategy for combating emerging infectious diseases. This potential has prompted researchers to investigate its efficacy against various viruses, including those responsible for influenza and HIV.

The role of fluorinated pyridines in anticancer therapy is another area where 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one has demonstrated significant promise. Its structural features allow it to interact with key proteins involved in cell proliferation and survival. Preclinical studies have shown that derivatives of this compound can induce apoptosis in cancer cells while sparing healthy cells. This selectivity is critical for developing treatments that minimize side effects associated with traditional chemotherapy.

Environmental considerations also play a role in the research and application of 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one. Efforts have been made to develop synthetic routes that minimize waste generation and energy consumption. Green chemistry principles have been applied to optimize processes, ensuring that the production of this compound is both sustainable and environmentally friendly.

The future prospects for 5-Fluoro-3-(hydroxymethyl)pyridin-2(1H)-one are vast, with ongoing research uncovering new applications and refining existing ones. As our understanding of molecular interactions continues to evolve, this compound is likely to play an increasingly important role in pharmaceutical development. Its unique combination of structural features makes it a versatile tool for scientists working across multiple disciplines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)